$FUSZ: nFusz CEO Rory Cutaia Tells How He Made People

New Post Public Reply Private Reply Replies (0) Message Board
SHEEPWOLF
818
$FUSZ: nFusz CEO Rory Cutaia Tells How He Made People Millionaires, and Will Do It Again, on iHeart Radio

Rory Cutaia Talks with Michael Yorba on CEO Money on Talk Radio 1190
DALLAS, TX - December 1, 2017 -- nFusz, Inc. (FUSZ) CEO Rory J. Cutaia told iHeart Radio listeners yesterday how he made investors, company members and employees millionaires when he sold his last company, and how he’s planning to do it all over again with nFusz. The Chief Executive Officer talked candidly with host Michael Yorba on CEO Money, iHeart’s Talk Radio 1190 AM Dallas/Fort Worth, about how he is now disrupting the $38 billion CRM industry.
A video from the segment, accompanying this press release is available here.
“I started my career at a prominent law firm, representing some of the top entrepreneurs the world has ever produced. I consider myself a recovering lawyer,” said nFusz CEO Rory J. Cutaia. “I left the legal profession to become an entrepreneur myself, and founded a company called Telx, which created the defacto standard for the telecom industry, called colocation. I sold that company for $200M, our investors received more than eighteen times their invested capital, I made a lot of millionaires in the company, distributed stock to all the employees and even the receptionist was able to purchase a home and change her life. Telx is a great company, in fact it was recently sold again, about a year ago, for almost $2 billion,” said Mr. Cutaia.
Now Mr. Cutaia is taking on the $38 billion CRM industry with nFusz’s flagship product, notifiCRM, which was launched in September of this year. The software product is on the watch list for Sales Force, NetSuite and other CRM giants. While other CRM companies focus on tracking engagement, notifiCRM creates it, using interactive video with clickable calls-to-action right in the video. Users can send succinct, effective, corporate compliant and interactive videos through email, SMS messages, or on social media.
notifiCRM allows anyone to become a video marketing and sales expert, starting at just $9.95/month, plus a modest one-time activation fee. Users learn exactly how video recipients are behaving and responding, right in the system. It is the only platform that offers users analytics on who watched a video, how many times, for how long, and which calls to action were engaged. The user can easily, visually identify who are the most interested prospects, and re- target them, right through the system. Calls to action can include: purchasing a product, initiating a phone call or email, launching or auto-launching a website, or scheduling an appointment, all without leaving the original interactive video.
Most people today, can’t sell. Our product removes selling skills out of the sales process by using proprietary, interactive video technology with corresponding analytics,” said Mr. Cutaia. “In today’s video-centric world, if you’re not using video to market yourself, you’re easily ignored. If you want to be effective, you must deliver messaging in a way that is engaging and succinct, while empowering the user to act on-demand, seamlessly. The only way to achieve this is through video, and not just video, interactive video. That’s the solution, and customers are seeing increased conversion rates by up to 600%,” continued Cutaia.
nFusz CEO Rory J. Cutaia will be a regular guest on IHeart’s Talk Radio 1190 AM Dallas/Fort Worth, every Wednesday at 12pm PT/3pm ET.

https://nfusz.com/wp-content/uploads/2018/01/...3017v2.pdf
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 5

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading

Top 5 Most Recently Viewed Articles

New Oriental Reports Major Financial Growth for Latest Quarter

Updated Category News Views 103

New Oriental Education & Technology Group Inc. Financial Results Overview New Oriental Education & Technology Group Inc. (NYSE: EDU) has recently unveiled its unaudited financial results for the second fiscal quarter ended November 30. This marks a significant period in the company's journey, highlighting an impressive rise in net revenues and overall financial...

Continue Reading
Continued Confidence Among CEOs and Investors in 2026 Growth

Updated Category News Views 137

Continued Confidence Among CEOs and Investors in 2026 Growth Recent insights reveal that CEO and investor expectations for growth, mergers and acquisitions (M&A), and hiring are notably high. However, these aspirations come with caution, spurred by challenges related to global trade, geopolitical uncertainties, and rapid technological advancements. High Expectations for...

Continue Reading
Understanding S&P 500 E-Mini Trends: Are We in for a Shift?

Updated Category News Views 201

The S&P 500 E-Mini futures market saw quite the ruckus back then. As traders scanned the weekly charts, smaller candlestick patterns hinted at a shift in momentum that got everyone on edge. They had their eyes glued to that 20-week exponential moving average (EMA)—a critical support level that bulls hoped would come through for them as they scrambled for a double-bottom...

Continue Reading
Understanding Recent Legal Challenges Facing Nutex Health Inc.

Updated Category News Views 127

The Current Legal Landscape for Nutex Health Inc. Nutex Health Inc. is currently facing significant legal challenges that have sparked interest among its investors and market watchers. These challenges are crucial to understanding the company’s financial health and future prospects. Recently, a class action lawsuit was announced against the Company, raising concerns...

Continue Reading
BellRing Brands Faces Legal Scrutiny: Investors Encouraged to Engage

Updated Category News Views 120

Introduction to the Investigation Bragar Eagel & Squire, P.C., a respected law firm focused on investor rights, is currently investigating potential claims against BellRing Brands Inc. (BRBR). This inquiry aims to determine whether the company violated federal securities laws or engaged in unlawful business practices, impacting their shareholders. Investors who have...

Continue Reading